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Abstract
Background: The goal of this study was to determine if left ventricular (LV) global longitudinal strain (GLS) predicts
heart failure (HF) readmission in patients with acute decompensated heart failure.
Methods and results: Two hundred ninety one patients were enrolled at the time of admission for acute
decompensated heart failure between January 2011 and September 2013. Left ventricle global longitudinal strain
(LV GLS) by velocity vector imaging averaged from 2, 3 and 4-chamber views could be assessed in 204 out of 291
(70%) patients. Mean age was 63.8 ± 15.2 years, 42% of the patients were males and 78% were African American or
Hispanic. Patients were followed until the first HF hospital readmission up to 44 months. Patients were grouped
into quartiles on the basis of LV GLS. Kaplan-Meier curves showed significantly higher readmission rates in patients
with worse LV GLS (log-rank p < 0.001). After adjusting for age, sex, history of ischemic heart disease, dementia, New
York Heart Association class, LV ejection fraction, use of angiotensin converting enzyme inhibitors or angiotensin
receptor blockers, systolic and diastolic blood pressure on admission and sodium level on admission, worse LV GLS was
the strongest predictor of recurrent HF readmission (p < 0.001). The ejection fraction was predictive of readmission in
univariate, but not in multivariate analysis.
Conclusion: LV GLS is an independent predictor of HF readmission after acute decompensated heart failure with a
higher risk of readmission in case of progressive worsening of LV GLS, independent of the ejection fraction.
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Background
Left ventricular ejection fraction (LVEF) is the most
commonly used parameter of systolic function [1]. It is es-
sential for the management of heart failure (HF) patients,
particularly to guide therapy and for prognostication [2, 3].
Recently there has been great interest in development of
novel quantitative methods to assess systolic function [4, 5].
One promising technique is two-dimensional speckle track-
ing which can provide information on the rate of segmental
and global myocardial deformation. Global Longitudinal
Strain (GLS) is defined as the change of length of a tissue
normalized to its original length ([L-L0]/L0).
Prior studies have reported the usefulness of GLS for
prognostic stratification of HF outpatients [6–9], how-
ever only one previous study found this parameter to be
predictive in patients admitted to the hospital with acute
decompensated heart failure (ADHF) in a mostly white
European patient population (98%) [10].
We hypothesized that GLS could be a useful predictor
of readmission in a mostly African American patient
population hospitalized with ADHF.
Methods
This was a single-center retrospective observational
study that involved chart and medical record reviews,
and analysis of de-identified clinical data and previously
recorded echocardiographic tracings. Chart review was
performed on 291 patients, aged ≥18 years, who were
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admitted to the University of Illinois Hospital and
Health Sciences System (UI-Health) with the primary
admission diagnosis of ADHF from January 2011 thru
September 2013.
Inclusion criteria consisted of patients aged 18 years
or older who had been admitted between January
2011 and September 2013 at the University of Illinois
Hospital and Health Sciences System with the diagno-
sis of heart failure, either as new diagnosis or as
acute decompensation of chronic HF, had a complete
Transthoracic Echocardiography, and did not meet
any of the exclusion criteria.
Exclusion criteria consisted of age under 18 years,
diagnosis of terminal cancer, diagnosis of diseases, other
than heart failure that could cause volume overload,
such as end-stage renal disease requiring hemodialysis,
severe liver disease, pericardial tamponade or constric-
tion, acute myocardial infarction, and primary valvular
disease, diagnosis of acute coronary syndrome, proce-
dures that might affect prognosis (cardiac bypass sur-
gery, coronary artery stenting), and lack of contact with
the hospital. The diagnosis of ADHF was confirmed if
the admitting cardiologist included heart failure as the
primary admitting diagnosis and the documented phys-
ical examination laboratory and radiologic findings were
consistent with this diagnosis. Following the index HF
admission the medical record was assessed to determine
hospital readmission, with a follow-up period of up to
44 months. Patients with a non-cardiovascular death
prior to HF readmission were censored. Data was
obtained from the comprehensive review of the medical
record and cardiologist’s admission note regarding med-
ical history and physical examination. The baseline char-
acteristics of patients were collected upon hospital
admission except the New York Heart functional class
(NYHA) that was obtained from the most recent clinic
visit when the patient was clinically stable prior to the
index admission. When admitted, all patients were in
NYHA class III or IV.
Transthoracic echocardiography and global longitudinal
strain
Standard 4-chamber, 3-chamber and 2-chamber apical
views and parasternal short-axis views of the left ven-
tricle were obtained using a commercially available ultra-
sound system. All images were stored digitally and
analyzed with offline software (Syngo Dynamics 9.0 soft-
ware, Siemens Medical Solutions). The majority of
echocardiography studies were performed within 24 h
after admission, with all studies being completed by 48 h
post-admission. We used these images to calculate GLS
and EF that were included in the analysis.
Speckle tracking for myocardial strain was performed
using Velocity Vector Imaging software (Siemens
Medical Systems, Erlangen, Germany). A digital loop
was acquired from apical 2–3 and 4 chamber views. The
GLS was the average result of three measurements for
each view. The software calculated the endocardial aver-
age strain values from 6 left ventricle segments for a
total of 18 segments, therefore the GLS was the result of
the average of 18 segments. We obtained GLS only in
the case of adequate tracking quality at least in 5 of the
6 segments per view. LV ejection fraction was averaged
from the three apical views by automated endocardial
tracking of end-diastolic and end-systolic volumes. All
measurements were made blinded to other results and
clinical details.
Adequacy of measurements
Multiple studies have demonstrated the low measure-
ment variability for GLS [6–10]. In our software, left
ventricle endocardial borders were manually traced at
the end-diastole in ECG-gated long axis views. Subse-
quently, the software’s automatic border tracking algo-
rithm, which tracks image features throughout the
whole cardiac cycle, was applied. Accurate tracking was
ascertained by visual assessment of all borders. Images
with inadequate tracking of the endocardial were ex-
cluded from the analysis.
Outcome
Readmission to UI-Health for HF following the index
ADHF admission was assessed using the electronic
medical record.
Statistical analysis
The number of patients and percentages were calculated
for categorical variables. Means, standard deviations,
and medians were calculated for continuous variables.
Receiver operating characteristic (ROC) curve was used
to assess the optimal GLS threshold value which maxi-
mized the average of sensitivity and specificity for pre-
dicting HF admission. The area under the curve, which
was a measure of the discriminatory power of the pre-
dictor, ranged from 0.5 to 1. Clinical characteristics were
compared among patients categorized by quartiles of
GLS, using the Chi-square test for categorical variables
and t-test for continuous variables. Univariate and multi-
variate cox proportional hazard models were used to
examine the association of GLS and HF readmission.
Variables significantly correlated with outcomes on
univariate analysis (p < 0.05) or known to influence
outcomes were incorporated into the multivariate
analyses. Accordingly, hazard ratios (HR) and 95% confi-
dence interval (CI) were calculated. The Kaplan-Meier
curves and log-rank tests were used to compare the time
to first heart failure readmission across quartiles of GLS.
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Statistical analyses were conducted using IBM SPSS 21
(Armonk, NY). The significance level was set at 0.05.
Results
Population characteristics
In 204 (70%) patients, LV GLS by velocity vector im-
aging of the 2, 3 and 4-chamber views could be assessed.
As shown in Table 1, mean age was 63.8 ± 15.2 years,
42% were male, and ethnicity distribution was 71%
African Americans, 7% Caucasian and 7% Hispanics, the
remaining 15% a mixture of other minorities. 49 patients
had heart failure with preserved ejection fraction
(HFpEF) (EF > 50%). The average LVEF was 40% and the
average NYHA functional class during the clinic visit
prior to their index hospitalization was 2.03. None of the
patients was treated with coronary revascularization,
implantable cardioverter defibrillator or cardiac resyn-
chronization therapy after index hospitalization.
The area under the ROC curve for prediction of HF
readmission using LV GLS was 0.783 (Fig. 1). Patients
were grouped into quartiles according to LV GLS as fol-
lows, < −14.15%, −14.15% to −10.55%, −10.54% to
−6.41% and > −6.41% demonstrating increased readmis-
sion with worse strain quartiles. Baseline characteristics
of patients with a GLS above and below the threshold
value are summarized in Table 1.
Readmission
A total of 113 patients (55%) had at least one readmis-
sion. In the first quartile there were 10 (9%) patients
with at least one readmission, 24 patients (21%) in the
second quartile, 38 patients (34%) in the third quartile
and 41 patients (36%) in the fourth quartile. Kaplan-
Meier curves (Fig. 2) demonstrated significantly higher
admission rate in the more altered GLS group (p <
0.001). On univariate Cox proportional hazard analyses
(Table 2), more altered GLS was significantly associated
with HF admissions, either as continuous variable (HR
1.17, CI 1.12-1.23, p <0.001) or with lower quartiles of
GLS −14.15 to −10.55 (HR 3.1, CI 1.46-6.74, p 0.003),
Table 1 Baseline characteristics of the entire cohort and by quartiles of GLS
Characteristic Whole
population
LV GLS P Value
< −14.15 –14.5 to −10.55 –10.54 to −6.41 > −6.41
Age (years) 63.8 ± 15 66.3 ± 14 63.4 ± 15.8 65.7 ± 13.9 59.7 ± 16.3 0.116
Male 87 (42.4%) 11 (21.6%) 19 (37.3%) 25 (48.1%) 32 (62.7%) <0.001
Sodium level 138.3 ± 3.4 138.1 ± 4.2 139 ± 3 138.7 ± 3.4 137.5 ± 2.9 0.153
Creatinine 2.2 ± 2.4 2.6 ± 3.6 2.6 ± 2.5 1.7 ± 1.2 1.8 ± 1.5 0.163
LVEF 40.4 ± 17.4 60.4 ± 7.5 47.8 ± 11.6 30.9 ± 10.4 22.3 ± 5.9 <0.001
Medication use
ACEI or ARBs 140 (69.7%) 25 (49%) 32 (65.3%) 39 (78%) 44 (86.3%) <0.001
β-Blocker 173 (86.1%) 37 (72.5%) 43 (87.8%) 47 (94%) 46 (90.2%) 0.011
Hydralazine 55 (27.5% 14 (27.5%) 21 (43.8%) 9 (18%) 11 (21.6%) 0.023
Ca channel Blockers 45 (22.6%) 17 (33.3%) 19 (39.6%) 6 (12%) 3 (6%) <0.001
Loop diuretics 164 (81.6%) 41 (80.4%) 37 (75.5%) 41 (82%) 45 (88.2%) 0.43
Aldosterone-antagonists 19 (9.7%) 1 (2%) 3 (6.3%) 5 (10.4%) 10 (19.6%) 0.021
NYHA functional class
Class I 55 (28.8%) 17 (36.2%) 16 (34%) 14 (28.6%) 8 (16.7%)
Class II 78 (40.8%) 19 (40.4%) 15 (31.9%) 24 (49%) 20 (41.7%) 0.087
Class III 55 (28.8%) 9 (19.1%) 16 (34%) 10 (20.4%) 20 (41.7%)
Class IV 3 (1.6%) 2 (4.3%) 0 1 (2%) 0
Blood pressure (mmHg)
Systolic 148.7 ± 38.4 158.5 ± 35.9 166.5 ± 38 145.2 ± 36.6 124.7 ± 29.7 <0.001
Diastolic 84.9 ± 21.6 83.1 ± 23.5 89.1 ± 22.2 86.1 ± 21.9 81.3 ± 18.2 0.28
Heart rate (bpm) 86.1 ± 21.5 79.2 ± 19.1 86 ± 20.3 87.7 ± 22.2 91.6 ± 23.1 0.032
History of ischemic heart disease 80 (39%) 13 (25.5%) 23 (45.1%) 27 (51.9%) 17 (33.3%) 0.029
Chronic obstructive pulmonary disease 30 (14.6%) 6 (11.8%) 10 (19.6%) 6 (11.5%) 8 (15.7%) 0.617
Diabetes 79 (38.5%) 15 (29.4%) 23 (45.1%) 24 (46.2%) 17 (33.3%) 0.206
Hypertension 190 (93.1%) 46 (90.2%) 50 (98%) 49 (94.2%) 45 (90%) 0.324
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−10.54 and −6.41% (HR 7.4, CI 3.55-15.39, p <0.001),
and > −6.41% (HR 7.8, CI 3.79-16.34, p <0.001).
Additional variables significantly associated with HF
admission in univariate analysis included LVEF (p
<0.001), NYHA functional class III (p 0.01), systolic
blood pressure (p < 0.001), diastolic blood pressure (p
0.025), history of ischemic heart disease (p 0.021),
dementia (p 0.018) sodium level (p 0.018) and angioten-
sin converting enzyme inhibitors-angiotensin receptor
blockers (ACEI-ARBs) use (p 0.008). In the multivariate
analysis (Table 3), after adjusting for age, sex, history of
ischemic heart disease, dementia, NYHA class, LV
Fig. 1 ROC curve. The area under the ROC curve for prediction of
HF readmission using LV GLS was 0.783 (p < 0.001)
Fig. 2 Kaplan-Meier curves. Kaplan-Meier curves showing higher heart failure readmissions in patients within worse LV GLS quartiles (Q). Q1 < −14.15,
Q2 -14.15 to 10.55, Q3 -10.54 to −6.41, Q4 > −6.41
Table 2 Univariate analyses of factors that were shown to be
significantly correlated to HF readmissions
HF Readmission
Variable Hazard ratio 95% CI p-value
LV GLS –14.15 to –10.55 3.144 1.46–6.74 0.003
LV GLS –10.54 to 6.41 7.40 3.55–15.39 <0.001
LV GLS > −6.41 7.87 3.79–16.34 <0.001
LV GLS as a continuous variable a 1.17 1.12–1.23 <0.001
LVEF 0.97 0.96–0.98 <0.001
Age 1.01 0.99–1.02 0.099
Male 1.11 0.77–1.61 0.566
NYHA functional class II 1.3 0.77–2.19 0.314
NYHA functional class III 2.01 1.18–3.41 0.01
NYHA functional class IV 0.92 0.12–6.87 0.937
Systolic blood pressure 0.98 0.98–0.99 <0.001
Diastolic blood pressure 0.99 0.98–0.99 0.025
Heart rate 1 0.99–1.01 0.137
Creatinine 0.9 0.82–1 0.052
Sodium level 0.93 0.88–0.98 0.018
History of ischemic heart disease 1.55 1.07–2.24 0.021
Diabetes 1 0.68–1.46 0.983
Hypertension 1.45 0.59–3.55 0.418




ACEI-ARBs 1.83 1.17–2.86 0.008
aA different model with the same variables was performed using LV GLS as a
continuous variable
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ejection fraction, use of ACEI or ARBs, systolic and dia-
stolic blood pressure on admission and sodium level on
admission, worse LV GLS was the strongest predictor of
recurrent HF readmission either as continuous variable
(HR 1.23, CI 1.09-1.4, p = 0.001) or using the cut-off
point of −14.15 to −10.55 (HR 3.6, CI 1.26–7.9, p 0.014),
between −10.54 and −6.41% (HR 5.19, CI 1.7-15.82, p
<0.001), and > −6.41% (HR 5.3, CI 1.43–19.6, p <0.001).
Ejection fraction was a univariate predictor for readmis-
sion, but not a multivariate predictor. The small number
of patients with preserved LVEF precluded a useful ana-
lysis of this subgroup.
A dedicated statistical analysis to evaluate the correl-
ation between GLS and all-cause readmission did not
demonstrate a statistically significant correlation (data
not shown).
Discussion
In this study, we demonstrate that after adjusting for fac-
tors that can affect clinical outcomes, LV GLS is a strong
and independent predictor of HF readmission following
an index admission for ADHF. This is the first study to
show GLS can predict readmission in a racially diverse
group of patients with ADHF.
We know of only two other studies to assess strain in
patients with ADHF. One of the previously published
studies differed from our study in several important
ways [11]. Whereas our study included patients with
both heart failure with reduced ejection fraction (HFrEF)
and HFpEF, the previous study appears to have focused
on HFrEF. Furthermore, they found global circumferen-
tial strain (GCS) to predict outcome and not GLS. Our
study found GLS to be an independent predictor. GLS is
thought to be an early marker of subclinical LV dysfunc-
tion, whereas GCS becomes abnormal later in the course
of myocardial disease [12]. It is unclear why they did not
find GLS to be predictive, as one would expect this par-
ameter to become abnormal before GCS. One might
hypothesize that GLS would be a better predictor than
GCS in a lower risk group due to its ability to detect
myocardial dysfunction at an earlier stage.
The only other study to demonstrate GLS as a pre-
dictor of readmission [10] had a population consisting of
98% white Europeans and their follow-up was only
30 days. This differs from our study which included a
largely African American patient population. This is an
important discovery considering data exists to suggest
African American patients with heart failure remodel
differently than whites, raising the possibility that GLS
would predict differently in this patient population [13].
Despite dramatic improvement in outcomes with med-
ical therapy for heart failure, readmission rates remain
high, with approximately 50% of HF patients rehospita-
lized within 6 months of discharge [14]. Although stud-
ies have found factors that can predict readmission in
large administrative databases, assembling a risk model
that can reliably predict readmission in individual pa-
tients has been less than successful [15, 16]. The ability
to identify a group at high risk for readmission using
GLS might allow for resources to be directed towards
these individuals in order to reduce the readmission
rate.
Limitations
This was a single center study with information being
obtained in a retrospective manner. The clinical use of
GLS is limited considering its feasibility in only 70% of
cases in our study. Also GLS evaluation by echocardiog-
raphy requires good quality images in order to obtain re-
liable measurements. Two dimensional and Doppler
echocardiographic parameters were not included in the
present study.
Table 3 Multivariate Cox regression analysis incorporating factors that were shown to be significantly correlated with HF readmissions
in univariate analyses
Variable Number/Mean/Percentage Hazard Ratio 95% Confidence Interval p-value
LV GLS Quartile 2 (−14.15 to −10.55) N = 51 3.16 1.26–7.90 0.014
LV GLS Quartile 3 (−10.54 to −6.41) N = 52 5.19 1.70–15.82 0.004
LV GLS Quartile 4 (> − 6.41) N = 51 5.30 1.43–19.60 0.012
LV GLS as a continuous variablea −10.6 ± 4.7% 1.23 1.09–1.40 0.001
Age 63.8 ± 15 1.02 1.002–1.03 0.027
Left ventricular ejection fraction 40 ± 17% 0.98 0.95–1.02 0.288
History of ischemic heart disease 39% 1.13 0.71–1.78 0.608
NYHA III 29% 1.79 0.98–3.29 0.060
Use of ACEI/ARBs 70% 0.96 0.565–1.65 0.894
Systolic blood pressure 149 ± 38 0.999 0.99–1.01 0.689
Sodium level 138 ± 3 0.94 0.88–1.00 0.53
aA different model with the same variables was performed using LV GLS as a continuous variable
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Conclusion
Our study is the first to demonstrate GLS as a predictor
of readmission in a largely minority patient population
with ADHF, which was independent of LVEF and other
known clinical risk predictors. Further study to deter-
mine if GLS can impact outcomes in these patients is
warranted.
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